Weight loss drug reduces diabetes risk by 80%, according to ICL research
February 27, 2017Research and Development, Sales and Marketing diabetes, icl, liraglutide
Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …
Celgene announces shock departure of COO
February 27, 2017Medical Communications, Sales and Marketing Celgene
Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …
AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation
February 24, 2017Sales and Marketing AstraZeneca, EMA
AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …
Ex-GSK SVP instated as CMO at PureTech
February 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PureTech Health
PureTech Health, a cross-disciplinary biopharmaceutical company, announced that it had appointed Atul Pande as the Chief Medical Officer. Pande had …
Top Ten most popular articles on Pharmafile.com this week
February 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and this week in pharma has seen a slew of positive clinical trial results released in Crohn’s …
Developing talent and partnership to create new medicines
February 24, 2017Medical Communications ABPI
The ABPI discusses how investing in R&D education and collaboration can reap long-term benefits to the pharmaceutical industry and the …
India’s NPPA identifies 634 non-compliant drug pricings
February 24, 2017Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa
India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …
Death in trial of Roche’s potential blockbuster haemophilia drug
February 24, 2017Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia
Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …
EFPIA names new first female Director General Nathalie Moll
February 24, 2017Business Services, Medical Communications, Sales and Marketing EFPIA, appointment
Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …
Takeda collaborates to launch wearable-tech depression study
February 23, 2017Medical Communications, Research and Development Takeda, depression, mental health, wearable tech
Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …
BMS temporarily expands Board with three new additions
February 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb
Bristol-Myers Squibb has bolstered its Board of Directors with the appointment of three Directors, a move which temporarily expands its …
China’s insurance expansion boon to global pharma
February 23, 2017Sales and Marketing AstraZeneca, China, GSK, Shire
China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …
Sun Pharma inaugurates first Egypt production facility
February 23, 2017Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma
Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …
First biosimilar for European cancer treatment given approval
February 23, 2017Sales and Marketing biosimilar, celltrion
The first biosimilar will be made available in Europe to match the indications of Roche’s best-selling cancer drug, Rituxan. The …
Novartis’ Zykadia scores priority review and breakthrough designation from FDA
February 23, 2017Sales and Marketing Novartis, zykadia
Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …
CSO loses position at DNA sequencing company after admitting fraud
February 23, 2017Medical Communications Karmagenes
Pranav Ullal, formerly of Chief Scientific officer of Karmagenes, has been removed from his position after a paper he published …
Pfizer’s Remicade biosimilar displays similar efficacy
February 22, 2017Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra
Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …
Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics
Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
Roche and Discuva extend agreement to develop target antimicrobials
February 22, 2017Research and Development, Sales and Marketing Discuva, Roche
Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
Rabbit virus proves effective in treatment of multiple myeloma
February 22, 2017Research and Development multiple myeloma
A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
